Abbott Laboratories is a global healthcare company involved in the discovery, development, manufacture, and sale of diverse healthcare products. It operates through four segments: Established Pharmaceutical Products, which focuses on international sales of branded generic pharmaceuticals; Diagnostic Products, which provides diagnostic systems and tests globally; Nutritional Products, offering a wide range of adult and pediatric nutrition products worldwide; and Medical Devices, which includes products for rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care. The ABT stock yearly return is shown above.
The yearly return on the ABT stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2025 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ABT annual return calculation with any dividends reinvested as applicable (on ex-dates).
|